A scientific committee chaired has taken care to put together a program that covers the most relevant issues in the field today.
A new review explores how targeting gut bacteria and fungi interactions may help manage chronic intestinal inflammation
23 Nov 2017by Andreu Prados
A recent review article explores the role of the interactions between bacteria and fungi in Crohn’s disease and potential strategies to target the gut microbiota in gastrointestinal diseases.
Report covers take-home points from the 2017 Gut Microbiota for Health World Summit in Paris
19 Jul 2017by GMFH Editing Team
The GMFH editing team is pleased to bring you the Gut Summit 2017 official report.
GMFH releases Nutrition and Gut Microbiota Workshop report from 6th Gut Microbiota for Health World Summit
19 Jul 2017by GMFH Editing Team
The workshop —called “Nutrition and the human gut microbiome: What should health professionals know for their daily practice?”— addressed issues and questions relevant to nutrition practice.
A new study has identified a gut microbial signature for Crohn’s disease that could avoid invasive diagnostic testing
13 Mar 2017by Andreu Prados
A recent study, led by Dr. Chaysavanh Manichanh from the Group of Physiology and Digestive Physiopathology of the Vall d’Hebron Research Institute in Barcelona (Spain), has identified for the first time a group of 8 bacterial taxa that could discriminate CD and non-CD independently of geographical region.
Gut microbiota may be involved in the pathogenesis of ankylosing spondylitis
23 Feb 2017by Andreu Prados
A recent review, led by Dr. Hai Lu from the Department of Orthopedic Surgery at The Third Affiliated Hospital of Southern Medical University in Guangzhou (China), discusses the existing evidence for the role of gut microbiota in ankylosing spondylitis.
Gut bacterial and fungal community interactions identified for first time as a factor in Crohn’s disease
25 Nov 2016by Andreu Prados
A recent study, led by Prof. Mahmoud A. Ghannoum from the Centre for Medical Mycology at the Case Western Reserve University in Cleveland, Ohio, USA, has identified new specific interkingdom bacteria and fungi interactions that may be key players in Crohn’s disease.
Diarrhoea-causing bacteria may promote growth of a bacterial pathobiont linked to Crohn’s disease in mice
18 Nov 2016by Paul Enck
A recent study, led by Prof. Brian K. Coombes from the Department of Biochemistry and Biomedical Sciences at the McMaster University in Hamilton, Ontario (Canada), has found that AIEC colonization along with acute infectious gastroenteritis worsened clinical outcome and increased mortality in mice, and also that the infectious diarrhoea caused by microbes promoted growth of AIEC and heightened the inflammatory state in the gut.
Exploring the clinical usefulness of the low-FODMAP diet for Crohn’s disease
16 Sep 2016by Kristina Campbell
The observed success of the low-FODMAP diet in reducing gastrointestinal (GI) symptoms in IBS made a group of researchers ask whether the diet could also address functional GI symptoms in those with inflammatory bowel diseases (IBDs) such as Crohn's disease. This idea was explored in a recent study from the group at Monash University (Australia) that originally developed and tested the low-FODMAP diet.
Inflammatory bowel disease (IBD) is a family of intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) that are characterized by chronic and recurring periods of severe colonic (UC) or intestinal (CD) inflammation and extraintestinal symptoms.